Stocks / NASDAQ / Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc

Our Opinion

Adaptimmune Therapeutics plc is on the Cruelty Free Investing use of animals list because they use animal testing for their drugs.

Company Description

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR)  and produce TCR therapeutic candidates for administration to patients.